MarketAnalysisMarketAnalysis
NYSE:ABT

Abbott Laboratories - NYSE:ABT - Comprehensive analysis

Free evaluation through quantitative algorithms Abbott Laboratories - NYSE:ABT

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

4.59

Market

50

Sector

55

Gross Profit Growth Over Prior Year

5.03

Market

46

Sector

54

EBITDA Growth Over Prior Year

2.4

Market

33

Sector

46

EBITA Growth Over Prior Year

2.05

Market

38

Sector

38

EBIT Growth Over Prior Year

3.82

Market

38

Sector

41

Earnings from Cont. Ops. Growth Over Prior Year

135

Market

98

Sector

93

Net Income Growth Over Prior Year

135

Market

96

Sector

91

Normalized Net Income Growth Over Prior Year

3.43

Market

43

Sector

33

Diluted EPS before Extra Growth Over Prior Year

135

Market

97

Sector

91

A/R Growth Over Prior Year

5.48

Market

64

Sector

66

Inventory Growth Over Prior Year

-5.72

Market

20

Sector

18

PPE Net Growth Over Prior Year

4.05

Market

58

Sector

70

Total Assets Growth Over Prior Year

11.2

Market

84

Sector

68

Tangible Book Value Growth Over Prior Year

194

Market

98

Sector

94

Common Equity Growth Over Prior Year

23.5

Market

89

Sector

78

Cash from Ops. Growth Over Prior Year

17.86

Market

75

Sector

58

CAPEX Growth Over Prior Year

0.23

Market

50

Sector

65

Dividend per Share Growth Over Prior Year

7.69

Market

71

Sector

98

Levered Free Cash Flow Growth Over Prior Year

12.41

Market

64

Sector

57

Unlevered Free Cash Flow Growth Over Prior Year

10.59

Market

60

Sector

55

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

56

Market

68

Sector

55

SG&A Margin %

26.5

Market

77

Sector

39

EBITDA Margin %

25.5

Market

52

Sector

88

EBITA Margin %

22.3

Market

60

Sector

89

EBIT Margin %

17.87

Market

47

Sector

88

Earnings from Cont. Ops Margin %

31.9

Market

94

Sector

98

Net Income Margin %

31.9

Market

94

Sector

98

Net Income Avail. for Common Margin %

31.8

Market

94

Sector

98

Normalized Net Income Margin %

10.64

Market

54

Sector

89

Levered Free Cash Flow Margin %

13.37

Market

62

Sector

84

Unlevered Free Cash Flow Margin %

14.21

Market

60

Sector

82

Return on Assets %

6.06

Market

58

Sector

88

Return on Capital %

7.95

Market

50

Sector

87

Return on Equity %

30.9

Market

77

Sector

96

Return on Common Equity %

31

Market

77

Sector

97

Total Asset Turnover

0.54

Market

55

Sector

67

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 29
Momentum: 82
Growth: 64
Profitability: 67

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

5.46

Market

69

Sector

66

TEV/LTM EBITDA

20.7

Market

84

Sector

85

P/LTM Normalized EPS

53

Market

84

Sector

80

P/BV

4.84

Market

63

Sector

79

TEV/LTM Unlevered FCF

38.5

Market

79

Sector

84

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

0.99

Market

76

Sector

83

3M Price Performance

13.64

Market

90

Sector

89

6M Price Performance

11.78

Market

87

Sector

84

9M Price Performance

24

Market

87

Sector

88

1Y Price Performance

15.96

Market

72

Sector

85

Start analyzing Abbott Laboratories - NYSE:ABT with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports